Use of the combination of teriflunomide and interferon beta for treating multiple sclerosis

Details for Australian Patent Application No. 2010271467 (hide)

Owner Sanofi-Aventis U.S. LLC

Inventors Byrnes, William; Douillet, Patrice; Frangin, Gerald

Agent Watermark

Pub. Number AU-A-2010271467

PCT Pub. Number WO2011/005907

Priority 61/225,342 14.07.09 US; 09305669.5 10.07.09 EP; 61/350,957 03.06.10 US; 61/286,148 14.12.09 US

Filing date 8 July 2010

Wipo publication date 13 January 2011

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/005907 Priority application(s): WO2011/005907

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010271481-Tea brewing apparatus

2010271456-Toothpaste droplets